Verdane

Verdane is a Stockholm-based growth equity and buyout firm driving the digital transition of healthcare services and software across Northern Europe. The firm sits closer to private equity than classic venture capital, which shapes how it engages with healthcare companies: focus is on businesses with substantial revenue, demonstrated unit economics, and platforms that can be scaled through buy-and-build, geographic expansion, or operational improvement. Healthcare interest spans digital health and health IT, with founders running profitable or near-profitable software and services businesses fitting the mandate most cleanly. AI is not a stated focus.

Verdane invests at Series B, Series C, and Growth stages with checks of $5M to $25M, sized to support meaningful minority growth investments or majority buyout structures depending on the situation. The geographic mandate covers the Nordics and broader Northern Europe, with Stockholm headquartered alongside additional regional offices in the firm’s network. Companies in the cohort typically have established commercial traction, multi-year operating histories, and the ability to absorb governance and reporting standards typical of growth equity and PE-style investors. Founders should expect detailed financial diligence and active engagement with strategy, M&A, and operational excellence.

Named partners and specific portfolio companies are not detailed in the materials reviewed, so this profile reflects limited public information about the team and named healthcare investments. Founders considering Verdane should prepare a robust commercial and financial dataset, an articulated strategy for scaling within and beyond the Nordics, and a view on how Verdane’s growth and operational resources fit their plan. The most productive engagement targets companies that have already demonstrated repeatability and are ready for a step change in scale.